
J&J’s experimental antiviral drug shows promise against COVID-19 and emerging coronaviruses
Johnson & Johnson’s pharmaceutical arm, Janssen, has shared early preclinical findings on its new antiviral drug, JNJ-9676, which shows promise in combating COVID-19 and other serious coronaviruses. This early-stage experimental drug has been tested in …